New horizons in cellular regulation by inositol polyphosphates: Insights from the pancreatic β-cell

Pharmacological Reviews

Volumn 65, Issue 2, 2013, Pages 641-669

  Barker, Christopher J ^a   Berggren, Per Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; G PROTEIN COUPLED RECEPTOR; GLUCOSE; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 3,4,5,6 TETRAKISPHOSPHATE; INOSITOL POLYPHOSPHATE; INSULIN; PHYTIC ACID; PYROPHOSPHATE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL PHOSPHATE; INOSITOL-3,4,5,6-TETRAKISPHOSPHATE;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CALCIUM REGULATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CYTOPLASM; EXOCYTOSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CALCIUM; EXOCYTOSIS; GLUCOSE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; INOSITOL PHOSPHATES; INSULIN; INSULIN-SECRETING CELLS; PHYTIC ACID;

MLCS; MLOWN;

EID: 84880938957     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.112.006775     Document Type: Review

References (204)

1. Abdullah M., Hughes PJ, Craxton A, Gigg R, Desai T, Marecek JF, Prestwich GD, and Shears SB (1992) Purification and characterization of inositol-1,3,4-trisphosphate 5/6-kinase from rat liver using an inositol hexakisphosphate affinity column. J Biol Chem 267:22340-22345.
2. Ahrén B. (2005) Type 2 diabetes, insulin secretion and beta-cell mass. Curr Mol Med 5:275-286.
3. Alcázar-Román A. R, Bolger TA, and Wente SR (2010) Control of mRNA export and translation termination by inositol hexakisphosphate requires specific interaction with Gle1. J Biol Chem 285:16683-16692.
4. Ali N., Craxton A, and Shears SB (1993) Hepatic Ins(1,3,4,5)P4 3-phosphatase is compartmentalized inside endoplasmic reticulum. J Biol Chem 268:6161-6167.
5. Ammälä C., Larsson O, Berggren PO, Bokvist K, Juntti-Berggren L, Kindmark H, and Rorsman P (1991) Inositol trisphosphate-dependent periodic activation of a Ca (2+)-activated K+ conductance in glucose-stimulated pancreatic beta-cells. Nature 353:849-852.
6. Ashcroft F. M and Rorsman P (1990) ATP-sensitive K+ channels: a link between B-cell metabolism and insulin secretion. Biochem Soc Trans 18:109-111.
7. Azevedo C., Burton A, Bennett M, Onnebo SM, and Saiardi A (2010) Synthesis of InsP7 by the Inositol Hexakisphosphate Kinase 1 (IP6K1). Methods Mol Biol 645: 73-85.
8. Azevedo C., Burton A, Ruiz-Mateos E, Marsh M, and Saiardi A (2009) Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release. Proc Natl Acad Sci USA 106:21161-21166.
9. Balcazar N., Sathyamurthy A, Elghazi L, Gould A, Weiss A, Shiojima I, Walsh K, and Bernal-Mizrachi E (2009) mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability. J Biol Chem 284: 7832-7842.
10. Barker C. J and Berggren PO (1999) Inositol hexakisphosphate and beta-cell stimulussecretion coupling. Anticancer Res 19 (5A):3737-3741.
11. Barker C. J and Berggren PO (2010) The role of inositol and the principles of labelling, extraction, and analysis of inositides in mammalian cells. Methods Mol Biol 645: 1-19.
12. Barker C. J, French PJ, Moore AJ, Nilsson T, Berggren PO, Bunce CM, Kirk CJ, and Michell RH (1995) Inositol 1,2,3-trisphosphate and inositol 1,2-and/or 2,3-bisphosphate are normal constituents of mammalian cells. Biochem J 306: 557-564.
13. Barker C. J, Illies C, Fiume R, Gaboardi GC, Yu J, and Berggren PO (2009a) Diphosphoinositol pentakisphosphate as a novel mediator of insulin exocytosis. Adv Enzyme Regul 49:168-173.
14. Barker C. J, Illies C, Gaboardi GC, and Berggren PO (2009b) Inositol pyrophosphates: structure, enzymology and function. Cell Mol Life Sci 66:3851-3871.
15. Barker C. J, Leibiger IB, Leibiger B, and Berggren PO (2002) Phosphorylated inositol compounds in beta-cell stimulus-response coupling. Am J Physiol Endocrinol Metab 283:E1113-E1122.
16. Barker C. J, Nilsson T, Kirk CJ, Michell RH, and Berggren PO (1994) Simultaneous oscillations of cytoplasmic free Ca2+ concentration and Ins(1,4,5)P3 concentration in mouse pancreatic beta-cells. Biochem J 297:265-268.
17. Barker C. J, Wright J, Hughes PJ, Kirk CJ, and Michell RH (2004) Complex changes in cellular inositol phosphate complement accompany transit through the cell cycle. Biochem J 380:465-473.
18. Beauvois M. C, Merezak C, Jonas JC, Ravier MA, Henquin JC, and Gilon P (2006) Glucose-induced mixed [Ca2+]c oscillations in mouse beta-cells are controlled by the membrane potential and the SERCA3 Ca2+-ATPase of the endoplasmic reticulum. Am J Physiol Cell Physiol 290:C1503-C1511.
19. Berggren P. O, Arkhammar P, Islam MS, Juntti-Berggren L, Khan A, Kindmark H, Köhler M., Larsson K, Larsson O, and Nilsson T, et al. (1993) Regulation of cytoplasmic free Ca2+ in insulin-secreting cells. Adv Exp Med Biol 334:25-45.
20. Berggren P. O and Barker CJ (2008) A key role for phosphorylated inositol compounds in pancreatic beta-cell stimulus-secretion coupling. Adv Enzyme Regul 48:276-294.
21. Berggren P. O, Rorsman P, Arkhammar P, and Nilsson T (1990) Mechanisms of action of entero-insular hormones and neural input on the insulin secretory process. Biochem Soc Trans 18:119-122.
22. Berggren P. O, Yang SN, Murakami M, Efanov AM, Uhles S, Köhler M, Moede T, Fernström A., Appelskog IB, and Aspinwall CA, et al. (2004) Removal of Ca2+ channel beta3 subunit enhances Ca2+ oscillation frequency and insulin exocytosis. Cell 119:273-284.
23. Bergsten P. (2002) Role of oscillations in membrane potential, cytoplasmic Ca2+, and metabolism for plasma insulin oscillations. Diabetes 51 (Suppl 1):S171-S176.
24. Berridge M. J (2007) Inositol trisphosphate and calcium oscillations. Biochem Soc Symp 1-7.
25. Berridge M. J (2009) Inositol trisphosphate and calcium signalling mechanisms. Biochim Biophys Acta 1793:933-940.
26. Berridge M. J and Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315-321.
27. Best L. and Malaisse WJ (1983) Stimulation of phosphoinositide breakdown in rat pancreatic islets by glucose and carbamylcholine. Biochem Biophys Res Commun 116:9-16.
28. Bhandari R., Juluri KR, Resnick AC, and Snyder SH (2008) Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci USA 105:2349-2353.
29. Bhandari R., Saiardi A, Ahmadibeni Y, Snowman AM, Resnick AC, Kristiansen TZ, Molina H., Pandey A, Werner JK Jr, and Juluri KR, et al. (2007) Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event. Proc Natl Acad Sci USA 104:15305-15310.
30. Biden T. J, Peter-Riesch B, Schlegel W, and Wollheim CB (1987) Ca2+-mediated generation of inositol 1,4,5-triphosphate and inositol 1,3,4,5-tetrakisphosphate in pancreatic islets. Studies with K+, glucose, and carbamylcholine. J Biol Chem 262: 3567-3571.
31. Biden T. J, Prentki M, Irvine RF, Berridge MJ, and Wollheim CB (1984) Inositol 1,4,5-trisphosphate mobilizes intracellular Ca2+ from permeabilized insulin-secreting cells. Biochem J 223:467-473.
32. Blondel O., Moody MM, Depaoli AM, Sharp AH, Ross CA, Swift H, and Bell GI (1994) Localization of inositol trisphosphate receptor subtype 3 to insulin and somatostatin secretory granules and regulation of expression in islets and insulinoma cells. Proc Natl Acad Sci USA 91:7777-7781.
33. Borradaile N. M, Han X, Harp JD, Gale SE, Ory DS, and Schaffer JE (2006) Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res 47:2726-2737.
34. Brehm M. A, Schenk TM, Zhou X, Fanick W, Lin H, Windhorst S, Nalaskowski MM, Kobras M., Shears SB, and Mayr GW (2007) Intracellular localization of human Ins(1,3,4,5,6)P5 2-kinase. Biochem J 408:335-345.
35. Brownlee M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625.
36. Buzzi F., Xu L, Zuellig RA, Boller SB, Spinas GA, Hynx D, Chang Z, Yang Z, Hemmings BA, and Tschopp O, et al. (2010) Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. Mol Cell Biol 30:601-612.
37. Cabrera O., Berman DM, Kenyon NS, Ricordi C, Berggren PO, and Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103:2334-2339.
38. Caffrey J. J, Darden T, Wenk MR, and Shears SB (2001) Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity. FEBS Lett 499:6-10.
39. Chakraborty A., Kim S, and Snyder SH (2011) Inositol pyrophosphates as mammalian cell signals. Sci Signal 4:re1.
40. Chakraborty A., Koldobskiy MA, Bello NT, Maxwell M, Potter JJ, Juluri KR, Maag D, Kim S., Huang AS, and Dailey MJ, et al. (2010) Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 143: 897-910.
41. Chakraborty A., Koldobskiy MA, Sixt KM, Juluri KR, Mustafa AK, Snowman AM, van Rossum D. B, Patterson RL, and Snyder SH (2008) HSP90 regulates cell survival via inositol hexakisphosphate kinase-2. Proc Natl Acad Sci USA 105:1134-1139.
42. Chamberlain P. P, Qian X, Stiles AR, Cho J, Jones DH, Lesley SA, Grabau EA, Shears SB, and Spraggon G (2007) Integration of inositol phosphate signaling pathways via human ITPK1. J Biol Chem 282:28117-28125.
43. Cheung J. C, Salerno B, and Hanakahi LA (2008) Evidence for an inositol hexakisphosphate-dependent role for Ku in mammalian nonhomologous end joining that is independent of its role in the DNA-dependent protein kinase. Nucleic Acids Res 36:5713-5726.
44. Chi H., Yang X, Kingsley PD, O'Keefe RJ, Puzas JE, Rosier RN, Shears SB, and Reynolds PR (2000) Targeted deletion of Minpp1 provides new insight into the activity of multiple inositol polyphosphate phosphatase in vivo. Mol Cell Biol 20: 6496-6507.
45. Clements R. S Jr and Rhoten WB (1976) Phosphoinositide metabolism and insulin secretion from isolated rat pancreatic islets. J Clin Invest 57:684-691.
46. Cobbold P. H and Cuthbertson KS (1990) Calcium oscillations: phenomena, mechanisms and significance. Semin Cell Biol 1:311-321.
47. Craxton A., Caffrey JJ, Burkhart W, Safrany ST, and Shears SB (1997) Molecular cloning and expression of a rat hepatic multiple inositol polyphosphate phosphatase. Biochem J 328:75-81.
48. Deleu S., Choi K, Pesesse X, Cho J, Sulis ML, Parsons R, and Shears SB (2006) Physiological levels of PTEN control the size of the cellular Ins(1,3,4,5,6)P(5) pool. Cell Signal 18:488-498.
49. Deriy L. V, Gomez EA, Jacobson DA, Wang X, Hopson JA, Liu XY, Zhang G, Bindokas VP, Philipson LH, and Nelson DJ (2009) The granular chloride channel ClC-3 is permissive for insulin secretion. Cell Metab 10:316-323.
50. Dhar-Chowdhury P., Harrell MD, Han SY, Jankowska D, Parachuru L, Morrissey A, Srivastava S., Liu W, Malester B, and Yoshida H, et al. (2005) The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the K(ATP) channel macromolecular complex and regulate its function. J Biol Chem 280:38464-38470.
51. Downes C. P, Gray A, Fairservice A, Safrany ST, Batty IH, and Fleming I (2005) The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups. Biochem Soc Trans 33:1303-1307.
52. Draskovic P., Saiardi A, Bhandari R, Burton A, Ilc G, Kovacevic M, Snyder SH, and Podobnik M (2008) Inositol hexakisphosphate kinase products contain diphosphate and triphosphate groups. Chem Biol 15:274-286.
53. Efanov A. M, Zaitsev SV, and Berggren PO (1997) Inositol hexakisphosphate stimulates non-Ca2+-mediated and primes Ca2+-mediated exocytosis of insulin by activation of protein kinase C. Proc Natl Acad Sci USA 94:4435-4439.
54. Elghazi L., Balcazar N, and Bernal-Mizrachi E (2006) Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function. Int J Biochem Cell Biol 38:157-163.
55. Folkmann A. W, Noble KN, Cole CN, and Wente SR (2011) Dbp5, Gle1-IP6 and Nup159: a working model for mRNP export. Nucleus 2:540-548.
56. Frederick J. P, Mattiske D, Wofford JA, Megosh LC, Drake LY, Chiou ST, Hogan BL, and York JD (2005) An essential role for an inositol polyphosphate multikinase, Ipk2, in mouse embryogenesis and second messenger production. Proc Natl Acad Sci USA 102:8454-8459.
57. Fujii M. and York JD (2005) A role for rat inositol polyphosphate kinases rIPK2 and rIPK1 in inositol pentakisphosphate and inositol hexakisphosphate production in rat-1 cells. J Biol Chem 280:1156-1164.
58. Gautam D., Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, and Deng C, et al. (2006) A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3:449-461.
59. Gersonde K. and Weiner M (1981-1982) The influence of infusion rate on the acute intravenous toxicity of phytic acid, a calcium-binding agent. Toxicology 22: 279-286.
60. Gilon P. and Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22:565-604.
61. Graf E., Empson KL, and Eaton JW (1987) Phytic acid. A natural antioxidant. J Biol Chem 262:11647-11650.
62. Greene D. A, Lattimer-Greene S, and Sima AA (1989) Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit Rev Neurobiol 5: 143-219.
63. Gromada J., Høy M, Renström E, Bokvist K, Eliasson L, Göpel S, and Rorsman P (1999) CaM kinase II-dependent mobilization of secretory granules underlies acetylcholine-induced stimulation of exocytosis in mouse pancreatic B-cells. J Physiol 518:745-759.
64. Hagar R. E and Ehrlich BE (2000) Regulation of the type III InsP3 receptor and its role in beta cell function. Cell Mol Life Sci 57:1938-1949.
65. Hanakahi L. A, Bartlet-Jones M, Chappell C, Pappin D, and West SC (2000) Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 102:721-729.
66. Harper J. L, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, and Daly JW (2003) Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol 65:329-338.
67. Healy J. A, Nilsson KR, Hohmeier HE, Berglund J, Davis J, Hoffman J, Kohler M, Li LS, Berggren PO, and Newgard CB, et al. (2010) Cholinergic augmentation of insulin release requires ankyrin-B. Sci Signal 3:ra19.
68. Hellman B., Gylfe E, Grapengiesser E, Lund PE, and Berts A (1992) Cytoplasmic Ca2+ oscillations in pancreatic beta-cells. Biochim Biophys Acta 1113:295-305.
69. Henquin J. C, Garcia MC, Bozem M, Hermans MP, and Nenquin M (1988) Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology 122:2134-2142.
70. Henquin J. C, Jonas JC, and Gilon P (1998) Functional significance of Ca2+ oscillations in pancreatic beta cells. Diabetes Metab 24:30-36.
71. Hidaka K., Kanematsu T, Caffrey JJ, Takeuchi H, Shears SB, and Hirata M (2003) The importance to chondrocyte differentiation of changes in expression of the multiple inositol polyphosphate phosphatase. Exp Cell Res 290:254-264.
72. Ho M. W, Yang X, Carew MA, Zhang T, Hua L, Kwon YU, Chung SK, Adelt S, Vogel G, and Riley AM, et al. (2002) Regulation of Ins(3,4,5,6)P(4) signaling by a reversible kinase/phosphatase. Curr Biol 12:477-482.
73. Hou J. C, Min L, and Pessin JE (2009) Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm 80:473-506.
74. Høy M., Berggren PO, and Gromada J (2003) Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells. J Biol Chem 278:35168-35171.
75. Høy M., Efanov AM, Bertorello AM, Zaitsev SV, Olsen HL, Bokvist K, Leibiger B, Leibiger I. B, Zwiller J, and Berggren PO, et al. (2002) Inositol hexakisphosphate promotes dynamin I-mediated endocytosis. Proc Natl Acad Sci USA 99: 6773-6777.
76. Hur K. Y, Jung HS, and Lee MS (2010) Role of autophagy in b-cell function and mass. Diabetes Obes Metab 12 (Suppl 2):20-26.
77. Illies C., Gromada J, Fiume R, Leibiger B, Yu J, Juhl K, Yang SN, Barma DK, Falck JR, and Saiardi A, et al. (2007) Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 318:1299-1302.
78. Irvine R. F (2005) Inositide evolution-towards turtle domination? J Physiol 566: 295-300.
79. Irvine R. F and Schell MJ (2001) Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2:327-338.
80. Ishihara H., Wada T, Kizuki N, Asano T, Yazaki Y, Kikuchi M, and Oka Y (1999) Enhanced phosphoinositide hydrolysis via overexpression of phospholipase C beta1 or delta1 inhibits stimulus-induced insulin release in insulinoma MIN6 cells. Biochem Biophys Res Commun 254:77-82.
81. Jacques-Silva M. C, Correa-Medina M, Cabrera O, Rodriguez-Diaz R, Makeeva N, Fachado A., Diez J, Berman DM, Kenyon NS, and Ricordi C, et al. (2010) ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc Natl Acad Sci USA 107:6465-6470.
82. Jahanshahi P., Wu R, Carter JD, and Nunemaker CS (2009) Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets. Endocrinology 150:607-615.
83. Jentsch T. J, Maritzen T, Keating DJ, Zdebik AA, and Thévenod F (2010) ClC-3-a granular anion transporter involved in insulin secretion? Cell Metab 12:307-308, author reply 309-310.
84. Joseph S. K and Hajnóczky G (2007) IP3 receptors in cell survival and apoptosis: Ca2+ release and beyond. Apoptosis 12:951-968.
85. Jovanovic S, Du Q, Crawford RM, Budas GR, Stagljar I, and Jovanovic A (2005) Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal K(ATP) channel. EMBO Rep 6:848-852.
86. Kamimura J., Wakui K, Kadowaki H, Watanabe Y, Miyake K, Harada N, Sakamoto M, Kinoshita A, Yoshiura K, and Ohta T, et al. (2004) The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family with type 2 diabetes mellitus. J Hum Genet 49:360-365.
87. Karaskov E., Scott C, Zhang L, Teodoro T, Ravazzola M, and Volchuk A (2006) Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147: 3398-3407.
88. Kelley G. G, Ondrako JM, and Reks SE (2001) Fuel and hormone regulation of phospholipase C beta 1 and delta 1 overexpressed in RINm5F pancreatic beta cells. Mol Cell Endocrinol 177:107-115.
89. Kim S., Kim SF, Maag D, Maxwell MJ, Resnick AC, Juluri KR, Chakraborty A, Koldobskiy M. A, Cha SH, and Barrow R, et al. (2011) Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metab 13:215-221.
90. Kong K. C and Tobin AB (2011) The role of M(3)-muscarinic receptor signaling in insulin secretion. Commun Integr Biol 4:489-491.
91. Larsson O., Barker CJ, Sjöholm A, Carlqvist H, Michell RH, Bertorello A, Nilsson T, Honkanen R. E, Mayr GW, and Zwiller J, et al. (1997) Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate. Science 278: 471-474.
92. Lee B., Jonas JC, Weir GC, and Laychock SG (1999) Glucose regulates expression of inositol 1,4,5-trisphosphate receptor isoforms in isolated rat pancreatic islets. Endocrinology 140:2173-2182.
93. Lee B. and Laychock SG (2001) Inositol 1,4,5-trisphosphate receptor isoform expression in mouse pancreatic islets: effects of carbachol. Biochem Pharmacol 61: 327-336.
94. Lee Y. S, Mulugu S, York JD, and O'Shea EK (2007) Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates. Science 316:109-112.
95. Leibiger B., Moede T, Uhles S, Barker CJ, Creveaux M, Domin J, Berggren PO, and Leibiger IB (2010) Insulin-feedback via PI3K-C2alpha activated PKBalpha/ Akt1 is required for glucose-stimulated insulin secretion. FASEB J 24: 1824-1837.
96. Leslie N. R, Davies EM, Sheffield DA, Tibarewal P, Fedele CG, and Mitchell CA (2012) The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease. Subcell Biochem 58:281-336.
97. Li D. Q, Jing X, Salehi A, Collins SC, Hoppa MB, Rosengren AH, Zhang E, Lundquist I, Olofsson CS, and Mörgelin M, et al. (2009) Suppression of sulfonylurea-and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein ClC-3. Cell Metab 10:309-315.
98. Lin H., Fridy PC, Ribeiro AA, Choi JH, Barma DK, Vogel G, Falck JR, Shears SB, York J. D, and Mayr GW (2009) Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases. J Biol Chem 284:1863-1872.
99. Llinás R., Sugimori M, Lang EJ, Morita M, Fukuda M, Niinobe M, and Mikoshiba K (1994) The inositol high-polyphosphate series blocks synaptic transmission by preventing vesicular fusion: a squid giant synapse study. Proc Natl Acad Sci USA 91:12990-12993.
100. Losito O., Szijgyarto Z, Resnick AC, and Saiardi A (2009) Inositol pyrophosphates and their unique metabolic complexity: analysis by gel electrophoresis. PLoS ONE 4: e5580.
101. Luo H. R, Saiardi A, Nagata E, Ye K, Yu H, Jung TS, Luo X, Jain S, Sawa A, and Snyder SH (2001) GRAB: a physiologic guanine nucleotide exchange factor for Rab3A, which interacts with inositol hexakisphosphate kinase. Neuron 31: 439-451.
102. Ma Y. and Lieber MR (2002) Binding of inositol hexakisphosphate (IP6) to Ku but not to DNA-PKcs. J Biol Chem 277:10756-10759.
103. Ma Z. A, Zhao Z, and Turk J (2012) Mitochondrial dysfunction and b-cell failure in type 2 diabetes mellitus. Exp Diabetes Res 2012:703538.
104. Maag D., Maxwell MJ, Hardesty DA, Boucher KL, Choudhari N, Hanno AG, Ma JF, Snowman A. S, Pietropaoli JW, and Xu R, et al. (2011) Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc Natl Acad Sci USA 108:1391-1396.
105. Macbeth M. R, Schubert HL, Vandemark AP, Lingam AT, Hill CP, and Bass BL (2005) Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 309:1534-1539.
106. Mendez C. F, Leibiger IB, Leibiger B, Høy M, Gromada J, Berggren PO, and Bertorello AM (2003) Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis. J Biol Chem 278:44753-44757.
107. Menniti F. S, Miller RN, Putney JW Jr, and Shears SB (1993) Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem 268:3850-3856.
108. Mikoshiba K. (2007) The IP3 receptor/Ca2+ channel and its cellular function. Biochem Soc Symp 9-22.
109. Misler S. (2010) The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy. Islets 2:210-224.
110. Morrison B. H, Bauer JA, Hu J, Grane RW, Ozdemir AM, Chawla-Sarkar M, Gong B, Almasan A., Kalvakolanu DV, and Lindner DJ (2002) Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene 21:1882-1889.
111. Morrison B. H, Bauer JA, Kalvakolanu DV, and Lindner DJ (2001) Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. J Biol Chem 276:24965-24970.
112. Morrison B. H, Haney R, Lamarre E, Drazba J, Prestwich GD, and Lindner DJ (2009) Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 28:2383-2392.
113. Mulugu S., Bai W, Fridy PC, Bastidas RJ, Otto JC, Dollins DE, Haystead TA, Ribeiro AA, and York JD (2007) A conserved family of enzymes that phosphorylate inositol hexakisphosphate. Science 316:106-109.
114. Nagata E., Luo HR, Saiardi A, Bae BI, Suzuki N, and Snyder SH (2005) Inositol hexakisphosphate kinase-2, a physiologic mediator of cell death. J Biol Chem 280: 1634-1640.
115. Nagata E., Saiardi A, Tsukamoto H, Okada Y, Itoh Y, Satoh T, Itoh J, Margolis RL, Takizawa S., and Sawa A, et al. (2011) Inositol hexakisphosphate kinases induce cell death in Huntington disease. J Biol Chem 286:26680-26686.
116. Nagata E., Saiardi A, Tsukamoto H, Satoh T, Itoh Y, Itoh J, Shibata M, Takizawa S, and Takagi S (2010) Inositol hexakisphosphate kinases promote autophagy. Int J Biochem Cell Biol 42:2065-2071.
117. Nagel A., Barker CJ, Berggren PO, and Illies C (2010) Diphosphosinositol polyphosphates and energy metabolism: assay for ATP/ADP ratio. Methods Mol Biol 645:123-131.
118. Nagy R., Grob H, Weder B, Green P, Klein M, Frelet-Barrand A, Schjoerring JK, Brearley C., and Martinoia E (2009) The Arabidopsis ATP-binding cassette protein AtMRP5/AtABCC5 is a high affinity inositol hexakisphosphate transporter involved in guard cell signaling and phytate storage. J Biol Chem 284:33614-33622.
119. Niki I. (1999) Ca2+ signaling and the insulin secretory cascade in the pancreatic betacell. Jpn J Pharmacol 80:191-197.
120. Olsen H. L, Hoy M, Zhang W, Bertorello AM, Bokvist K, Capito K, Efanov AM, Meister B, Thams P, and Yang SN, et al. (2003) Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic beta cells. Proc Natl Acad Sci USA 100:5187-5192.
121. Onnebo S. M and Saiardi A (2007) Inositol pyrophosphates get the vip1 treatment. Cell 129:647-649.
122. Onnebo S. M and Saiardi A (2009) Inositol pyrophosphates modulate hydrogen peroxide signalling. Biochem J 423:109-118.
123. Orchiston E. A, Bennett D, Leslie NR, Clarke RG, Winward L, Downes CP, and Safrany ST (2004) PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal. J Biol Chem 279:1116-1122.
124. Pace C. S and Clements RS (1981) Myo-inositol and the maintenance of beta-cell function in cultured rat pancreatic islets. Diabetes 30:621-625.
125. Park C. Y, Shcheglovitov A, and Dolmetsch R (2010) The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330: 101-105.
126. Patterson R. L, Boehning D, and Snyder SH (2004) Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 73:437-465.
127. Patterson R. L, van Rossum DB, Nikolaidis N, Gill DL, and Snyder SH (2005) Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci 30:688-697.
128. Petit P., Lajoix AD, and Gross R (2009) P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology. Eur J Pharm Sci 37: 67-75.
129. Piccolo E., Vignati S, Maffucci T, Innominato PF, Riley AM, Potter BV, Pandolfi PP, Broggini M, Iacobelli S, and Innocenti P, et al. (2004) Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway. Oncogene 23: 1754-1765.
130. Poyner D. R, Cooke F, Hanley MR, Reynolds DJ, and Hawkins PT (1993) Characterization of metal ion-induced [3H]inositol hexakisphosphate binding to rat cerebellar membranes. J Biol Chem 268:1032-1038.
131. Prasad A., Jia Y, Chakraborty A, Li Y, Jain SK, Zhong J, Roy SG, Loison F, Mondal S, and Sakai J, et al. (2011) Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. Nat Immunol 12:752-760.
132. Qu H. Q, Marchand L, Szymborski A, Grabs R, and Polychronakos C (2008) The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II. Genes Immun 9:264-266.
133. Quignard J. F, Rakotoarisoa L, Mironneau J, and Mironneau C (2003) Stimulation of L-type Ca2+ channels by inositol pentakis-and hexakisphosphates in rat vascular smooth muscle cells. J Physiol 549:729-737.
134. Ramadan J. W, Steiner SR, O'Neill CM, and Nunemaker CS (2011) The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 50:481-490.
135. Rana R. S, Sekar MC, Hokin LE, and MacDonald MJ (1986) A possible role for glucose metabolites in the regulation of inositol-1,4,5-trisphosphate 5-phosphomonoesterase activity in pancreatic islets. J Biol Chem 261:5237-5240.
136. Rana R. S, Sekar MC, Mertz RJ, Hokins LE, and MacDonald MJ (1987) Potentiation by glucose metabolites of inositol trisphosphate-induced calcium mobilization in permeabilized rat pancreatic islets. J Biol Chem 262:13567-13570.
137. Ravazzola M., Halban PA, and Orci L (1996) Inositol 1,4,5-trisphosphate receptor subtype 3 in pancreatic islet cell secretory granules revisited. Proc Natl Acad Sci USA 93:2745-2748.
138. Renström E., Ivarsson R, and Shears SB (2002) Inositol 3,4,5,6-tetrakisphosphate inhibits insulin granule acidification and fusogenic potential. J Biol Chem 277: 26717-26720.
139. Roach J. C, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC, Sheridan CM, Glusman G., Hood L, and Lernmark A, et al.; Swedish Childhood Diabetes Study Group;; Diabetes Incidence in Sweden Study Group (2006) Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet 79:614-627.
140. Rodriguez-Diaz R., Abdulreda MH, Formoso AL, Gans I, Ricordi C, Berggren PO, and Caicedo A (2011a) Innervation patterns of autonomic axons in the human endocrine pancreas. Cell Metab 14:45-54.
141. Rodriguez-Diaz R., Dando R, Jacques-Silva MC, Fachado A, Molina J, Abdulreda MH, Ricordi C., Roper SD, Berggren PO, and Caicedo A (2011b) Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med 17:888-892.
142. Rolland J. F, Henquin JC, and Gilon P (2002a) Feedback control of the ATP-sensitive K(+) current by cytosolic Ca(2+) contributes to oscillations of the membrane potential in pancreatic beta-cells. Diabetes 51:376-384.
143. Rolland J. F, Henquin JC, and Gilon P (2002b) G protein-independent activation of an inward Na(+) current by muscarinic receptors in mouse pancreatic beta-cells. J Biol Chem 277:38373-38380.
144. Rorsman P. and Renström E (2003) Insulin granule dynamics in pancreatic beta cells. Diabetologia 46:1029-1045.
145. Rösen P., Nawroth PP, King G, Möller W, Tritschler HJ, and Packer L (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 17: 189-212.
146. Safrany S. T, Caffrey JJ, Yang X, Bembenek ME, Moyer MB, Burkhart WA, and Shears SB (1998) A novel context for the 'MutT' module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase. EMBO J 17: 6599-6607.
147. Saiardi A. (2012) Cell signalling by inositol pyrophosphates. Subcell Biochem 59: 413-443.
148. Saiardi A., Bhandari R, Resnick AC, Snowman AM, and Snyder SH (2004) Phosphorylation of proteins by inositol pyrophosphates. Science 306:2101-2105.
149. Saiardi A., Caffrey JJ, Snyder SH, and Shears SB (2000) The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis. J Biol Chem 275:24686-24692.
150. Saiardi A., Resnick AC, Snowman AM, Wendland B, and Snyder SH (2005) Inositol pyrophosphates regulate cell death and telomere length through phosphoinositide 3-kinase-related protein kinases. Proc Natl Acad Sci USA 102:1911-1914.
151. Sarmah B. and Wente SR (2009) Dual functions for the Schizosaccharomyces pombe inositol kinase Ipk1 in nuclear mRNA export and polarized cell growth. Eukaryot Cell 8:134-146.
152. Sarmah B., Winfrey VP, Olson GE, Appel B, and Wente SR (2007) A role for the inositol kinase Ipk1 in ciliary beating and length maintenance. Proc Natl Acad Sci USA 104:19843-19848.
153. Schultze S. M, Jensen J, Hemmings BA, Tschopp O, and Niessen M (2011) Promiscuous affairs of PKB/AKT isoforms in metabolism. Arch Physiol Biochem 117: 70-77.
154. Seino S., Shibasaki T, and Minami K (2011) Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J Clin Invest 121:2118-2125.
155. Shears S. B (2001) Assessing the omnipotence of inositol hexakisphosphate. Cell Signal 13:151-158.
156. Shears S. B (2009) Diphosphoinositol polyphosphates: metabolic messengers? Mol Pharmacol 76:236-252.
157. Shears S. B, Ganapathi SB, Gokhale NA, Schenk TM, Wang H, Weaver JD, Zaremba A, and Zhou Y (2012) Defining signal transduction by inositol phosphates. Subcell Biochem 59:389-412.
158. Shears S. B, Gokhale NA, Wang H, and Zaremba A (2011) Diphosphoinositol polyphosphates: what are the mechanisms? Adv Enzyme Regul 51:13-25.
159. Shears S. B, Yang L, and Qian X (2004) Cell signaling by a physiologically reversible inositol phosphate kinase/phosphatase. Adv Enzyme Regul 44:265-277.
160. Speier S., Nyqvist D, Cabrera O, Yu J, Molano RD, Pileggi A, Moede T, Köhler M, Wilbertz J., and Leibiger B, et al. (2008a) Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 14:574-578.
161. Speier S., Nyqvist D, Köhler M, Caicedo A, Leibiger IB, and Berggren PO (2008b) Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat Protoc 3:1278-1286.
162. Spiers I. D, Barker CJ, Chung SK, Chang YT, Freeman S, Gardiner JM, Hirst PH, Lambert P. A, Michell RH, and Poyner DR, et al. (1996) Synthesis and iron binding studies of myo-inositol 1,2,3-trisphosphate and (+/-)-myo-inositol 1,2-bisphosphate, and iron binding studies of all myo-inositol tetrakisphosphates. Carbohydr Res 282:81-99.
163. Srikanth S. and Gwack Y (2012) Orai1, STIM1, and Their Associating Partners. J Physiol.
164. Stephens L., Radenberg T, Thiel U, Vogel G, Khoo KH, Dell A, Jackson TR, Hawkins PT, and Mayr GW (1993) The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s). J Biol Chem 268:4009-4015.
165. Stephens L. R and Irvine RF (1990) Stepwise phosphorylation of myo-inositol leading to myo-inositol hexakisphosphate in Dictyostelium. Nature 346:580-583.
166. Swayne L. A, Mezghrani A, Lory P, Nargeot J, and Monteil A (2010) The NALCN ion channel is a new actor in pancreatic b-cell physiology. Islets 2:54-56.
167. Szijgyarto Z., Garedew A, Azevedo C, and Saiardi A (2011) Influence of inositol pyrophosphates on cellular energy dynamics. Science 334:802-805.
168. Szumiel I. (2011) Autophagy, reactive oxygen species and the fate of mammalian cells. Free Radic Res 45:253-265.
169. Tamarina N. A, Kuznetsov A, and Philipson LH (2008) Reversible translocation of EYFP-tagged STIM1 is coupled to calcium influx in insulin secreting beta-cells. Cell Calcium 44:533-544.
170. Tamarina N. A, Kuznetsov A, Rhodes CJ, Bindokas VP, and Philipson LH (2005) Inositol (1,4,5)-trisphosphate dynamics and intracellular calcium oscillations in pancreatic beta-cells. Diabetes 54:3073-3081.
171. Tan Z., Bruzik KS, and Shears SB (1997) Properties of the inositol 3,4,5,6-tetrakisphosphate 1-kinase purified from rat liver. Regulation of enzyme activity by inositol 1,3,4-trisphosphate. J Biol Chem 272:2285-2290.
172. Tanimura A., Morita T, Nezu A, and Tojyo Y (2009) Monitoring of IP3 dynamics during Ca2+ oscillations in HSY human parotid cell line with FRET-based IP3 biosensors. J Med Invest 56 (Suppl):357-361.
173. Taylor C. W and Prole DL (2012) Ca(2+) Signalling by IP(3) Receptors. Subcell Biochem 59:1-34.
174. Tengholm A. and Gylfe E (2009) Oscillatory control of insulin secretion. Mol Cell Endocrinol 297:58-72.
175. Thomas H. E, McKenzie MD, Angstetra E, Campbell PD, and Kay TW (2009) Beta cell apoptosis in diabetes. Apoptosis 14:1389-1404.
176. Thore S., Dyachok O, Gylfe E, and Tengholm A (2005) Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca2+ in insulin-secreting beta-cells. J Cell Sci 118:4463-4471.
177. Thore S., Dyachok O, and Tengholm A (2004) Oscillations of phospholipase C activity triggered by depolarization and Ca2+ influx in insulin-secreting cells. J Biol Chem 279:19396-19400.
178. Torres J., Domínguez S, Cerdá MF, Obal G, Mederos A, Irvine RF, Díaz A, and Kremer C (2005) Solution behaviour of myo-inositol hexakisphosphate in the presence of multivalent cations. Prediction of a neutral pentamagnesium species under cytosolic/nuclear conditions. J Inorg Biochem 99:828-840.
179. Turner B. L, Papházy MJ, Haygarth PM, and McKelvie ID (2002) Inositol phosphates in the environment. Philos Trans R Soc Lond B Biol Sci 357:449-469.
180. Van Dijken P., de Haas JR, Craxton A, Erneux C, Shears SB, and Van Haastert PJ (1995) A novel, phospholipase C-independent pathway of inositol 1,4,5-trisphosphate formation in Dictyostelium and rat liver. J Biol Chem 270: 29724-29731.
181. Veiga N., Torres J, Mansell D, Freeman S, Domínguez S, Barker CJ, Díaz A, and Kremer C (2009) "Chelatable iron pool": inositol 1,2,3-trisphosphate fulfils the conditions required to be a safe cellular iron ligand. J Biol Inorg Chem 14:51-59.
182. Verbsky J., Lavine K, and Majerus PW (2005) Disruption of the mouse inositol 1,3,4,5,6-pentakisphosphate 2-kinase gene, associated lethality, and tissue distribution of 2-kinase expression. Proc Natl Acad Sci USA 102:8448-8453.
183. Voglmaier S. M, Bembenek ME, Kaplin AI, Dormán G, Olszewski JD, Prestwich GD, and Snyder SH (1996) Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor. Proc Natl Acad Sci USA 93:4305-4310.
184. Wang H., Falck JR, Hall TM, and Shears SB (2012) Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding. Nat Chem Biol 8: 111-116.
185. Wang Y., Deng X, Mancarella S, Hendron E, Eguchi S, Soboloff J, Tang XD, and Gill DL (2010) The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 330:105-109.
186. Warburg O. (1956) On respiratory impairment in cancer cells. Science 124:269-270.
187. Werner J. K Jr, Speed T, and Bhandari R (2010) Protein pyrophosphorylation by diphosphoinositol pentakisphosphate (InsP7). Methods Mol Biol 645:87-102.
188. Wuttke A., Idevall-Hagren O, and Tengholm A (2010) Imaging phosphoinositide dynamics in living cells. Methods Mol Biol 645:219-235.
189. Yamazaki H., Zawalich KC, and Zawalich WS (2010) Physiologic implications of phosphoinositides and phospholipase C in the regulation of insulin secretion. J Nutr Sci Vitaminol (Tokyo) 56:1-8.
190. Yang L., Reece JM, Cho J, Bortner CD, and Shears SB (2008) The nucleolus exhibits an osmotically regulated gatekeeping activity that controls the spatial dynamics and functions of nucleolin. J Biol Chem 283:11823-11831.
191. Yang S. N and Berggren PO (2005) Beta-cell CaV channel regulation in physiology and pathophysiology. Am J Physiol Endocrinol Metab 288:E16-E28.
192. Yang S. N, Larsson O, Bränström R, Bertorello AM, Leibiger B, Leibiger IB, Moede T, Köhler M., Meister B, and Berggren PO (1999) Syntaxin 1 interacts with the L(D) subtype of voltage-gated Ca(2+) channels in pancreatic beta cells. Proc Natl Acad Sci USA 96:10164-10169.
193. Yang S. N, Yu J, Mayr GW, Hofmann F, Larsson O, and Berggren PO (2001) Inositol hexakisphosphate increases L-type Ca2+ channel activity by stimulation of adenylyl cyclase. FASEB J 15:1753-1763.
194. Yang S. N, Shi J, Yang G, Li Y, Yu L, Shin OH, Bacaj T, Südhof TC, Yu J, and Berggren PO (2012) Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron. Proc Natl Acad Sci USA 109:12183-12188.
195. Yang X. and Shears SB (2000) Multitasking in signal transduction by a promiscuous human Ins(3,4,5,6)P(4) 1-kinase/Ins(1,3,4)P(3) 5/6-kinase. Biochem J 351:551-555.
196. Yano K., Petersen OH, and Tepikin AV (2004) Dual sensitivity of sarcoplasmic/ endoplasmic Ca2+-ATPase to cytosolic and endoplasmic reticulum Ca2+ as a mechanism of modulating cytosolic Ca2+ oscillations. Biochem J 383:353-360.
197. Ye R., Ni M, Wang M, Luo S, Zhu G, Chow RH, and Lee AS (2011) Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes. J Endocrinol 210:209-217.
198. Yoo S. H and Hur YS (2012) Enrichment of the inositol 1,4,5-trisphosphate receptor/ Ca2+ channels in secretory granules and essential roles of chromogranins. Cell Calcium 51:342-350.
199. York J. D (2006) Regulation of nuclear processes by inositol polyphosphates. Biochim Biophys Acta 1761:552-559.
200. York J. D, Odom AR, Murphy R, Ives EB, and Wente SR (1999) A phospholipase Cdependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 285:96-100.
201. Yu J., Berggren PO, and Barker CJ (2007) An autocrine insulin feedback loop maintains pancreatic beta-cell 3-phosphorylated inositol lipids. Mol Endocrinol 21: 2775-2784.
202. Yu J., Leibiger B, Yang SN, Caffery JJ, Shears SB, Leibiger IB, Barker CJ, and Berggren PO (2003) Cytosolic multiple inositol polyphosphate phosphatase in the regulation of cytoplasmic free Ca2+ concentration. J Biol Chem 278: 46210-46218.
203. Zhang S., Fritz N, Ibarra C, and Uhlén P (2011) Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem Res 36:1175-1185.
204. Zhou J. R and Erdman JW Jr (1995) Phytic acid in health and disease. Crit Rev Food Sci Nutr 35:495-508.